HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical experiences with the transjugular intrahepatic portocaval shunt (TIPS)].

Abstract
Twenty-five patients with liver cirrhosis and portal hypertension were admitted for creation of a transjugular intrahepatic portosystemic shunt (TIPS). The procedure was successful in 22 patients (technical success 88%). The mean portal pressure gradient was lowered from 24.5 mmHg before to 11.4 mmHg after TIPS. Two early and three late occlusions were observed (primary patency rate 78%). The rate of secondary interventions was 41%. Five times a hepatic vein stenosis was dilated and stented, two times an occluded shunt was recanalized, two times a new shunt was created parallel to an occluded (secondary patency rate within a maximum of 16 months 95%). In two patients sepsis occurred which was effectively treated with antibiotics, two patients died shortly after TIPS due to hepatorenal syndrome and hepatic failure, respectively. There was no recurrent bleeding. Two patients developed hepatic encephalopathy; both improved after protein restriction. The authors conclude that TIPS is an alternative procedure to shunt surgery, especially for patients who cannot benefit from sclerotherapy.
AuthorsK A Hausegger, G E Klein, F Flückiger, M H Sternthal, R Wilding, R Stauber
JournalRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin (Rofo) Vol. 159 Issue 3 Pg. 229-35 (Sep 1993) ISSN: 1438-9029 [Print] Germany
Vernacular TitleKlinische Erfahrungen mit dem transjugulären intrahepatischen portokavalen Shunt (TIPS).
PMID8374109 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Female
  • Humans
  • Hypertension, Portal (surgery)
  • Liver Cirrhosis (surgery)
  • Male
  • Middle Aged
  • Pilot Projects
  • Portasystemic Shunt, Surgical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: